SOURCE: VitalCare Diabetes Treatment Centers, Inc.

May 07, 2008 15:55 ET

VitalCare Board Passes Resolution to Decrease Total Authorized Shares

CARSON CITY, NV--(Marketwire - May 7, 2008) - VitalCare Diabetes Treatment Centers, Inc. (PINKSHEETS: VDTI), a Nevada corporation, today announced its Board of Directors has passed a resolution to reduce the total authorized shares from two (2) billion to 250 million. VitalCare currently has 40,250,000 shares outstanding, approximately 12,250,000 of those shares are free tradable.

About VitalCare Diabetes Treatment Centers, Inc.

VitalCare Diabetes Treatment Centers, Inc. is a company specializing in providing Administrative, Marketing, Business Development, Strategic Planning, Clinical Oversight and Clinical Management Services to the Diabetes Healthcare Sector, with an emphasis in bringing "Cutting Edge" medical devices and healthcare services direct to consumers, focusing on an emerging FDA approved, US and European Patented technology and treatment intervention for treating Type 1 and Type 2 Diabetes known as "Intracellular Activation Therapy (iCAT)."

Safe Harbor Statement: Forward-looking statements in this release with respect to VitalCare Diabetes Treatment Centers, Inc.'s business, financial condition and results of operations, as well as matters of timing and the prospective terms of the transaction described are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond VitalCare Diabetes Treatment Centers, Inc.'s control with respect to market acceptance of their technology and/or products, whether financing will be available, the effect of the application of acquisition accounting policies as well as certain other risk factors which are and may be detailed from time to time in VitalCare's filings with the Securities and Exchange Commission.

Contact Information

  • For Further Information Contact:
    VitalCare Diabetes Treatment Centers, Inc.
    Investor Relations:
    Jimmy McDougald
    Office: 1.909.981.9192
    Fax: 1.909.931.1780